top

Etiology and PathogenesisInsulin-like Growth Factors


Cancer Lett. 1986 Sep;32(3):229-34 (Cell Culture Study)


Abstract

Enhancement of insulin-like growth factor 2 receptors in glioblastoma

Sara VR, Prisell P, Sjogren B, Persson L, Boethius J, Enberg G

The somatomedins (IGF-1/IGF-2) are a family of growth-promoting hormones which have been identified in the human central nervous system where their specific receptors are distributed. 
The present study identified somatomedin receptors in glioblastoma and compared them with those found in normal brain. 
A significant enhancement in the binding of 125I-IGF-2 but not 125I-IGF-1 to glioblastoma membranes was found. 
A fourfold increase in IGF-2 receptor concentration was observed. 
These findings indicate enhanced expression of the IGF-2 receptor in glioblastoma.

PMID: 2945633 [PubMed - indexed for MEDLINE] 

Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2945633&dopt=Abstract


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP bottom